Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Tuncel

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|December 17, 2024
Redifferentiation Therapies in Thyroid Oncology: Molecular and Clinical AspectsPetra Petranović Ovčariček, Murat Tuncel, Atena Aghaee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
The Randomized, Phase 2 Trial LuCAP StudyMurat Tuncel, Gürsan Kaya, Oğuz Kodaz, et al.
Clinical Nuclear Medicine|July 16, 2021
68Ga-DOTATATE PET/CT in Pituitary CarcinomaGursan Kaya, Basak Soydas Turan, Selcuk Dagdelen, et al.
Tuberkuloz Ve Toraks|April 15, 2021
Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection?Rıza Doğan, Serkan Uysal, Ulaş Kumbasar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2026
Dual tracer PET/CT imaging for a patient with lipoadenoma: what Choline missed but Trivehexin revealedMurat Tuncel, Gürsan Kaya, Oğuz Kodaz, et al.
Cancers|June 26, 2026
Theranostic Approaches to Radioiodine-Refractory Differentiated Thyroid Cancer: A Narrative ReviewPetra Petranović Ovčariček, Murat Tuncel, Martin W Huellner, et al.
Seminars in Nuclear Medicine|March 19, 2024
Theranostics of Thyroid CancerLuca Giovanella, Murat Tuncel, Atena Aghaee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2024
The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?Michael C Kreissl, Petra Petranović Ovčariček, Alfredo Campenni, et al.
Cancers|August 28, 2025
Endocrine Adverse Events Induced by Cancer Treatments: The Role of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission TomographyLuca Giovanella, Murat Tuncel, Alfredo Campennì, et al.
The Prostate|March 15, 2023
Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with <sup>177</sup> Lu-PSMA-617. A single-center prospective observational studyTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 17, 2024
Redifferentiation Therapies in Thyroid Oncology: Molecular and Clinical AspectsPetra Petranović Ovčariček, Murat Tuncel, Atena Aghaee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
The Randomized, Phase 2 Trial LuCAP StudyMurat Tuncel, Gürsan Kaya, Oğuz Kodaz, et al.
Clinical Nuclear Medicine|July 16, 2021
68Ga-DOTATATE PET/CT in Pituitary CarcinomaGursan Kaya, Basak Soydas Turan, Selcuk Dagdelen, et al.
Tuberkuloz Ve Toraks|April 15, 2021
Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection?Rıza Doğan, Serkan Uysal, Ulaş Kumbasar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2026
Dual tracer PET/CT imaging for a patient with lipoadenoma: what Choline missed but Trivehexin revealedMurat Tuncel, Gürsan Kaya, Oğuz Kodaz, et al.
Cancers|June 26, 2026
Theranostic Approaches to Radioiodine-Refractory Differentiated Thyroid Cancer: A Narrative ReviewPetra Petranović Ovčariček, Murat Tuncel, Martin W Huellner, et al.
Seminars in Nuclear Medicine|March 19, 2024
Theranostics of Thyroid CancerLuca Giovanella, Murat Tuncel, Atena Aghaee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2024
The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?Michael C Kreissl, Petra Petranović Ovčariček, Alfredo Campenni, et al.
Cancers|August 28, 2025
Endocrine Adverse Events Induced by Cancer Treatments: The Role of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission TomographyLuca Giovanella, Murat Tuncel, Alfredo Campennì, et al.
The Prostate|March 15, 2023
Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with <sup>177</sup> Lu-PSMA-617. A single-center prospective observational studyTugce Telli, Murat Tuncel, Erdem Karabulut, et al.
Pageof 9